Nanoparticle-based drug delivery systems for controllable photodynamic cancer therapy

Eur J Pharm Sci. 2020 Mar 1:144:105213. doi: 10.1016/j.ejps.2020.105213. Epub 2020 Jan 10.

Abstract

Compared with the traditional treatment, photodynamic therapy (PDT) in the treatment of malignant tumors has the advantages of less damage to normal tissues, quick therapeutic effect, and ability to repeat treatments to the same site. However, most of the traditional photosensitizers (PSs) have severe skin photosensitization, poor tumor targeting, and low therapeutic effect in hypoxic tumor environment, which limit the application of PDT. Nanoparticle-based drug delivery systems can improve the targeting of PSs and release drugs with controllable photoactivity at predetermined locations, so as to achieve desired therapeutic effects with minimal side-effects. The present review summarizes the current nanoparticle platforms for PDT, and offers the description of different strategies including tumor-targeted delivery, controlled-release of PSs and the triggered photoactivity to achieve controllable PDT by nanoparticle-based drug delivery systems. The challenges and prospects for further development of intelligent PSs for PDT are also discussed.

Keywords: Cancer; Controllable photoactivity; Drug delivery; Nanoparticles; Photodynamic therapy.

Publication types

  • Review

MeSH terms

  • Drug Delivery Systems / methods
  • Humans
  • Nanoparticles / therapeutic use*
  • Neoplasms / drug therapy*
  • Photochemotherapy / methods*
  • Photosensitizing Agents / administration & dosage
  • Photosensitizing Agents / adverse effects
  • Photosensitizing Agents / chemistry*
  • Photosensitizing Agents / pharmacology*

Substances

  • Photosensitizing Agents